Kiniksa Pharmaceuticals, Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
22.20
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.78
|
3.18
|
2.40
|
307.69%
|
|
2022-06-30
|
-0.44
|
-0.29
|
0.15
|
34.09%
|
|
2022-03-31
|
-0.41
|
-0.36
|
0.05
|
12.20%
|
|
2021-12-31
|
-0.42
|
-0.53
|
-0.11
|
-26.19%
|
|
2021-09-30
|
-0.65
|
-0.44
|
0.21
|
32.31%
|
|
2021-06-30
|
-0.79
|
-0.61
|
0.18
|
22.78%
|
|
2021-03-31
|
-0.72
|
-0.72
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.62
|
-0.79
|
-0.17
|
-27.42%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
2.53
|
|
2021-12-31
|
-2.30
|
|
2020-12-31
|
-2.58
|
|
2019-12-31
|
-3.02
|
|
2018-12-31
|
-2.46
|
|
2017-12-31
|
0.02
|